ReviewEye (London, England)2023
The Peter Watson Memorial Lecture "Vision for the World".
Review in Eye (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- A Lightweight CNN for Multiclass Retinal Disease Screening with Explainable AI.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the 1990s attention was drawn to the huge global problem of blindness and vision loss; most of which was unnecessary, being preventable or treatable. This led to the global initiative, Vision 2020. Over the last 30 years a lot of progress has been made in developing and implementing eye care programmes to address this and particularly to reach underserved populations. In 2019 the World Health Organisation produced the World Report on Vision that sets a clear pathway to develop Integrated Person-centred Eye Care. Indicators have been developed to track progress and national governments are to report on their progress. Data on eye health and vision loss have been collected from multiple population-based studies and analysed by the Vision Loss Expert Group. These data show that although the prevalence rates of vision loss and blindness are decreasing around the world, the actual number of people affected is slowly increasing. This is due to both population growth and the aging of the population. To provide the equity in eye care that is required, attention needs to be paid to integrating eye care into primary care and linking it with other specialist services. An important step is the training and development of coordinated eye care teams that are resourced to meet their population-based needs and to monitor the progress being made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.